Davunetide

Pricing Availability   Qty
说明: Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo
别名: AL-108,NAP (peptide),NAPVSIPQ
纯度: ≥95% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for Davunetide

Davunetide is a highly potent active component of activity-dependent neuroprotective protein (ADNP). Prevents β-amyloid aggregation. Reduces hyperphosphorylated tau levels and increases tau-microtubule interactions; neuroprotective at femtomolar concentrations in vitro. Exerts neuroprotective effects in schizophrenia models associated with microtubule-autophagy insufficiency in MAP6-deficient mice. Modulates HIFs and VEGF expression and suppresses retinal cell apoptosis in an in vivo diabetic retinopathy model.

技术数据 for Davunetide

分子量 824.93
公式 C36H60N10O12
序列 NAPVSIPQ
储存 Store at -20°C
纯度 ≥95% (HPLC)
CAS Number 211439-12-2
PubChem ID 9832404
InChI Key DWLTUUXCVGVRAV-XWRHUKJGSA-N
Smiles O=C(N[C@@H](C)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H]([C@@H](C)CC)C(N2[C@@H](CCC2)C(N[C@@H](CCC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(N)=O)N

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for Davunetide

溶解性 Soluble to 1 mg/ml in water

产品说明书 for Davunetide

分析证书/产品说明书
选择另一批次:

参考文献 for Davunetide

参考文献是支持产品生物活性的出版物。

Bassan et al (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J.Neurochem. 72 1283 PMID: 10037502

Gozes et al (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze J.Pharmacol.Exp.Ther. 293 1091 PMID: 10869414

Sragovich et al (2017) ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease. Bioessays 39 doi: 10.1002 PMID: 28940660

Melo et al (2017) Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. Exp.Brain Res. 235 731 PMID: 27866262

D'Amico et al (2018) NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression. J.Cell Physiol. 233 1120 PMID: 28436035

Ivashko-Pachima et al (2017) ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy. Mol Psychiatry 22 1335 PMID: 28115743


If you know of a relevant reference for Davunetide, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Amyloid β Peptide Inhibitors

关键词: Davunetide, Davunetide supplier, AL-108, NAP, (peptide), NAPVSIPQ, Amyloid, Beta, Peptides, Microtubules, 6779, Tocris Bioscience

篇 Davunetide 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Davunetide 的引用文献。 您是否知道使用了 Tocris Davunetide 的优秀论文? 请告知我们.

Davunetide 的评论

目前没有该产品的评论。 Be the first to review Davunetide and earn rewards!

Have you used Davunetide?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.